Athanor Capital, LP Wave Life Sciences Ltd. Transaction History

Athanor Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $87,298 - $115,418	-15,451 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$5.61 - $12.01 $98,360 - $210,571	-17,533 Reduced 53.16%	15,451 $87,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $87,151 - $115,453	12,468 Added 60.77%	32,984 $260,000
Q3 2020 Nov 16, 2020	SELL	$8.49 - $19.54 $133,844 - $308,048	-15,765 Reduced 43.45%	20,516 $174,000
Q2 2020 Aug 13, 2020	BUY	$7.44 - $11.29 $269,930 - $409,612	36,281 New	36,281 $378,000
Q1 2020 May 14, 2020	SELL	$6.94 - $14.22 $241,165 - $494,145	-34,750 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $9,188 - $43,240	1,150 Added 3.42%	34,750 $279,000
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $228,123 - $326,060	11,900 Added 54.84%	33,600 $690,000
Q2 2019 Aug 13, 2019	BUY	$22.93 - $42.84 $497,581 - $929,628	21,700 New	21,700 $566,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.